Investors
ARCHAI-D is building the Resonant Intelligence Stack: QER-GATE (per-action ethical gating), ITR (lawful resonant synthesis with entry/exit), and IRST/QRT (multi-perspective fusion). We target high-stakes decisioning across AI safety, clinical research, security, robotics, and aerospace.
Why Invest Now
Category-defining tech
We unify design → decide → execute with measurable ethics and proof-of-decision (PoD). This is an execution layer most AI stacks lack.
Defensible IP
Umbrella provisional filed; divisional strategy for QER-GATE, ITR, IRST/QRT; trademarks pending. Quantum + TEE/PUF embodiments.
Cross-industry pull
Validated configs for clinical research planning, EV/batteries, security brokerage, and mission systems. Multiple pilots scoped.
Traction & Proof
- MVP/Alpha: exports PoD logs (JSON) and reports (PDF). Law compiler + soft-projectors operational.
- Demo domains: healthcare research planner, EV/battery ITR optimization, QuaRESS zero-trust broker.
- Auditability: signed PoD pack with attestation transcript (enclave/PUF).
Markets & Beachheads
Business Model
- Enterprise SaaS: per-seat + per-decision tiers; private cloud/VPC option.
- Licensing & OEM: QER-GATE module licensing (TEEs, devices, robots).
- Professional Services: lawset engineering, integrations, validation.
- Government/Grants: SBIR/NIH/DARPA-style funding for domain pilots.
Moat & IP
- Filed provisional (umbrella) + divisionals plan: QER-GATE, ITR, IRST/QRT.
- Quantum + Classical embodiments: swap-test and TEE/PUF sealed basis.
- PoD ledger: immutable audit artifacts; regulatory advantage.
- Lawset ecosystem: proprietary, versioned, domain-specific assets.
Team
Round Details
Terms (target):
- Pre-money valuation: $200M
- Round size (Seed): $5M
- Instrument: SAFE or Equity (lead investor preference)
- Use of proceeds: build, validate, sell (see breakdown)
Use of Funds (12–18 months):
- Core engineering (QER-GATE / ITR / IRST hardening): 35%
- Pilots & regulatory-grade validation (health/security/industrial): 20%
- Go-to-market (enterprise sales, marketing, certifications): 20%
- Cloud/TEE infra, security & compliance (SOC2/ISO): 10%
- Legal/IP (non-provisionals, PCT, trademarks): 10%
- Contingency/ops: 5%
Milestones & ROI Path
Illustrative Return Scenarios
- Strategic acquisition (Big Tech / Defense / MedTech): premium on IP + pilots + compliance readiness (3–7× seed entry typical; higher if ARR ≥ $10M).
- Series A: scale to multi-vertical ARR; maintain IP lead; internationalize with PCT.
Data Room & Contact
Data Room (under NDA): claims snapshot, PoD demo pack, lawset examples, pilot SOWs, financial model.
Investor Contact: Gregory Martínez — Commercial & Marketing Lead
Risk Factors (Summary)
- Enterprise adoption cycles and compliance timing.
- Talent and integration bandwidth with large customers.
- Competitive entrance; we counter with IP + PoD + lawset ecosystem.
This page is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. Any offering will be made pursuant to applicable laws and definitive documents.
